Polymyositis Initiation Involving Amlodipine Besylate

dc.contributor.author Golding, Raymund M
dc.contributor.author Giles, Lynton G F
dc.contributor.author Sokoya, Elke Marion
dc.date.accessioned 2014-09-30T06:10:33Z
dc.date.available 2014-09-30T06:10:33Z
dc.date.issued 2006
dc.description © 2006 R. M. Golding, L. G.F. Giles and E. M. Sokoya. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
dc.description.abstract Based on extensive blood pressure data and results from a scientific model of the analysis of the rate processes involved in polymyositis the evidence suggests that the polymyositis in a particular patient was initiated by taking the drug amlodipine besylate (norvasc). The method of our analysis should serve as a foundation in handling other drug related interactions.
dc.identifier.citation Golding, R.M., Giles, L.G. and Sokoya, E.M. (2006). Polymyositis Initiation Involving Amlodipine Besylate. American Journal of Immunology, 2(1) pp. 19-22.
dc.identifier.doi https://doi.org/10.3844/ajisp.2006.19.22 en
dc.identifier.issn 1553-619X
dc.identifier.rmid 2006017324
dc.identifier.uri http://hdl.handle.net/2328/32714
dc.oaire.license.condition.license CC-BY
dc.publisher Science Publications
dc.rights © 2006 R. M. Golding, L. G.F. Giles and E. M. Sokoya
dc.rights.holder © 2006 R. M. Golding, L. G.F. Giles and E. M. Sokoya.
dc.subject Polymyositis,
dc.subject blood pressure
dc.subject amlodipine besylate (norvasc)
dc.subject steroid therapy
dc.subject.forgroup 1109 Neurosciences
dc.title Polymyositis Initiation Involving Amlodipine Besylate
dc.type Article
local.contributor.authorOrcidLookup Sokoya, Elke Marion: https://orcid.org/0000-0001-8509-2044 en_US
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
101.97 KB
Adobe Portable Document Format
Publisher version